Table 2 Socio-demographic, lifestyle, and clinical characteristics of women with breast cancer in the SABCHO cohort by the number of chronic conditions at breast cancer diagnosis
Multimorbidity | |||||
|---|---|---|---|---|---|
No | Yes | Total | |||
Number of chronic conditions | 0–1 | 2 | ≥ 3 | p value | |
Number of chronic conditions, N (row %) | N = 1796 (55.1) | N = 954 (29.2) | N = 511 (15.7) | N = 3261 (100.0) | |
Age in years | < 0.001 | ||||
< 50 | 835 (46.5) | 314 (32.9) | 93 (18.2) | 1,242 (38.1) | |
≥ 50 | 961 (53.5) | 640 (67.1) | 418 (81.8) | 2,019 (61.9) | |
Ethnicity | < 0.001 | ||||
Asian | 173 (9.6) | 96 (10.1) | 79 (15.5) | 348 (10.7) | |
Black | 1,414 (78.7) | 770 (80.7) | 385 (75.3) | 2,569 (78.8) | |
Mixed | 68 (3.8) | 37 (3.9) | 29 (5.7) | 134 (4.1) | |
White | 141 (7.9) | 51 (5.3) | 18 (3.5) | 210 (6.4) | |
Marital status | < 0.001 | ||||
Not married | 1,056 (58.8) | 607 (63.6) | 348 (68.1) | 2,011 (61.7) | |
Married/Cohabiting | 740 (41.2) | 347 (36.4) | 163 (31.9) | 1,249 (38.3) | |
Highest level of education | < 0.001 | ||||
Primary education and below | 464 (25.9) | 307 (32.5) | 206 (40.6) | 977 (30.1) | |
Secondary education and above | 1,327 (74.1) | 639 (67.5) | 302 (59.4) | 2,268 (69.9) | |
Employment status | < 0.001 | ||||
Unemployed | 1,249 (69.5) | 709 (74.3) | 413 (80.8) | 2,371 (72.7) | |
Employed | 547 (30.5) | 245 (25.7) | 98 (19.2) | 890 (27.3) | |
Household socio-economic status (HSES) | 0.299 | ||||
0–5 (Low to medium) | 1,380 (76.8) | 739 (77.5) | 378 (74.0) | 2,497 (76.6) | |
6–7 (High) | 416 (23.2) | 215 (22.5) | 133 (26.0) | 764 (23.4) | |
aECOG | < 0.001 | ||||
0–1 | 1,656 (93.5) | 873 (92.8) | 444 (87.9) | 2,973 (92.4) | |
2–4 | 115 (6.5) | 68 (7.2) | 61 (12.1) | 244 (7.6) | |
bHospital | < 0.001 | ||||
CHBAH | 709 (39.5) | 358 (37.5) | 162 (31.7) | 1,229 (37.7) | |
CMJAH | 482 (26.8) | 218 (22.9) | 85 (16.6) | 785 (24.1) | |
Durban | 269 (15.0) | 181 (19.0) | 130 (25.4) | 580 (17.8) | |
Greys | 299 (16.6) | 172 (18.0) | 123 (24.1) | 594 (18.2) | |
Ngwelezana | 37 (2.1) | 25 (2.6) | 11 (2.2) | 73 (2.2) | |
Have you ever smoked? | 0.187 | ||||
No | 1,565 (87.1) | 850 (89.1) | 440 (86.1) | 2,855 (87.5) | |
Yes | 231 (12.9) | 104 (10.9) | 71 (13.9) | 406 (12.5) | |
Stage at diagnosis | 0.044 | ||||
Stages 1 and 2 | 728 (40.5) | 388 (40.7) | 237 (46.4) | 1,353 (41.5) | |
Stage 3 | 736 (41.0) | 415 (43.5) | 188 (36.8) | 1,339 (41.1) | |
Stage 4 | 332 (18.5) | 151 (15.8) | 86 (16.8) | 569 (17.4) | |
cReceptor subtype | 0.030 | ||||
ER + /PR + HER2- | 1,085 (60.4) | 595 (62.7) | 300 (58.8) | 1,975 (60.8) | |
ER + /PR + HER2 + | 307 (17.2) | 153 (16.1) | 76 (14.9) | 536 (16.5) | |
Er-&PR- HER2 + | 134 (7.5) | 52 (5.5) | 30 (5.9) | 216 (6.7) | |
Er-&PR- HER2- | 268 (15.0) | 149 (15.7) | 104 (20.4) | 521 (16.0) | |
Surgery | 0.463 | ||||
No | 613 (34.1) | 307 (32.2) | 163 (31.9) | 1,083 (33.2) | |
Yes | 1,183 (65.9) | 647 (67.8) | 348 (68.1) | 2,178 (66.8) | |
Chemotherapy | 0.001 | ||||
No | 419 (23.3) | 213 (22.3) | 155 (30.3) | 787 (24.1) | |
Yes | 1,377 (76.7) | 741 (77.7) | 356 (69.7) | 2,474 (75.9) | |
Radiation therapy | 0.143 | ||||
No | 920 (51.2) | 515 (54.0) | 284 (55.6) | 1,719 (52.7) | |
Yes | 876 (48.8) | 439 (46.0) | 227 (44.4) | 1,542 (47.3) | |